# Intec Pharma Ltd. — Form D

Intec Pharma Ltd. of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-19. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-05-19
- Form: D
- Accession: 0001213900-20-012942
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 4
- Date of first sale: 2020-05-04
- Revenue range: Decline to Disclose
- SEC file number: 021-367324

## Issuer

- Name: Intec Pharma Ltd.
- CIK: 0001638381
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 12 HARTOM STREET, JERUSALEM, L3, 777512
- Phone: 97225864657

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| William B Hayes | Director | New York, NY |
| HILA W KARAH | Director | NEW YORK, NY |
| JOHN W KOZARICH | Director | JERUSALEM, L3 |
| Anthony J Maddaluna | Director | New York, NY |
| JEFFREY A MECKLER | Director | TUCKER, GA |
| Roger J Pomerantz | Director | New York, NY |
| R. MICHAEL GENDREAU | Executive Officer | JERUSALEM, L3 |
| WALT A LINSCOTT | Executive Officer | NEW YORK, NY |
| JEFFREY A MECKLER | Executive Officer | TUCKER, GA |
| NADAV A NAVON | Executive Officer | JERUSALEM, L3 |
| NIR A SASSI | Executive Officer | NEW YORK, NY |

## More

- [CIK 1638381 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1638381&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-20-012942.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.